The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 349:300 July 17, 2003 Number 3
NextNext

Legislative Myopia on Stem Cells
Jeffrey M. Drazen, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Rosenthal, N.
-Related Article
 by Hochedlinger, K.
-PubMed Citation
The U.S. House of Representatives has voted to ban research on, and the use of, medical treatments derived from embryonic stem cells. This bill is shortsighted and has the potential to put many critical future advances in medicine beyond the reach of patients in the United States.

There are two distinct uses of embryonic stem cells. The first, for which there is no support among members of the scientific and medical communities, is the use of stem cells to create a genetically identical person. There is a de facto worldwide ban on such activities, and this ban is appropriate. The . . . [Full Text of this Article]


Related Letters:

Stem Cells
Allen L. J., Gerardi S., Drazen J. M.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:1481-1482, Oct 9, 2003. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.